Cargando…

Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy

PURPOSE: To evaluate the effects of intravitreal ranibizumab (IVR) treatment on the blood flow of the optic nerve head (ONH) and of retinal vessels of the peripapillary region of eyes with diabetic macular edema (DME) assessed using laser speckle flowgraphy (LSFG). METHODS: Forty eyes of 30 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Toto, Lisa, Evangelista, Federica, Viggiano, Pasquale, Erroi, Emanuele, D'Onofrio, Giada, Libertini, Daniele, Porreca, Annamaria, D'Aloisio, Rossella, Mariacristina, Parravano, Di Antonio, Luca, Di Nicola, Marta, Mastropasqua, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035512/
https://www.ncbi.nlm.nih.gov/pubmed/32104710
http://dx.doi.org/10.1155/2020/9496242
_version_ 1783500073347317760
author Toto, Lisa
Evangelista, Federica
Viggiano, Pasquale
Erroi, Emanuele
D'Onofrio, Giada
Libertini, Daniele
Porreca, Annamaria
D'Aloisio, Rossella
Mariacristina, Parravano
Di Antonio, Luca
Di Nicola, Marta
Mastropasqua, Rodolfo
author_facet Toto, Lisa
Evangelista, Federica
Viggiano, Pasquale
Erroi, Emanuele
D'Onofrio, Giada
Libertini, Daniele
Porreca, Annamaria
D'Aloisio, Rossella
Mariacristina, Parravano
Di Antonio, Luca
Di Nicola, Marta
Mastropasqua, Rodolfo
author_sort Toto, Lisa
collection PubMed
description PURPOSE: To evaluate the effects of intravitreal ranibizumab (IVR) treatment on the blood flow of the optic nerve head (ONH) and of retinal vessels of the peripapillary region of eyes with diabetic macular edema (DME) assessed using laser speckle flowgraphy (LSFG). METHODS: Forty eyes of 30 patients treated with IVR for DME were included in this prospective clinical study. Mean blur rate (MBR) and relative flow volume (RFV) of the ONH and of a superior retinal artery and an inferior retinal vein of the peripapillary region were measured using LSFG at baseline, 2 weeks (T1), and 1 month (T2) after IVR injection. In addition, best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were measured in all cases. RESULTS: The BCVA improved and CRT decreased significantly during the follow-up period (p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, CONCLUSION: IVR injection leads to a reduction of ocular blood flow both in the ONH and in the retinal peripapillary vessels associated with peripapillary vessel constriction. The reduction of CRT and related improvement of vision may be related to the changes in ocular blood flow.
format Online
Article
Text
id pubmed-7035512
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70355122020-02-26 Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy Toto, Lisa Evangelista, Federica Viggiano, Pasquale Erroi, Emanuele D'Onofrio, Giada Libertini, Daniele Porreca, Annamaria D'Aloisio, Rossella Mariacristina, Parravano Di Antonio, Luca Di Nicola, Marta Mastropasqua, Rodolfo Biomed Res Int Research Article PURPOSE: To evaluate the effects of intravitreal ranibizumab (IVR) treatment on the blood flow of the optic nerve head (ONH) and of retinal vessels of the peripapillary region of eyes with diabetic macular edema (DME) assessed using laser speckle flowgraphy (LSFG). METHODS: Forty eyes of 30 patients treated with IVR for DME were included in this prospective clinical study. Mean blur rate (MBR) and relative flow volume (RFV) of the ONH and of a superior retinal artery and an inferior retinal vein of the peripapillary region were measured using LSFG at baseline, 2 weeks (T1), and 1 month (T2) after IVR injection. In addition, best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were measured in all cases. RESULTS: The BCVA improved and CRT decreased significantly during the follow-up period (p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, CONCLUSION: IVR injection leads to a reduction of ocular blood flow both in the ONH and in the retinal peripapillary vessels associated with peripapillary vessel constriction. The reduction of CRT and related improvement of vision may be related to the changes in ocular blood flow. Hindawi 2020-02-10 /pmc/articles/PMC7035512/ /pubmed/32104710 http://dx.doi.org/10.1155/2020/9496242 Text en Copyright © 2020 Lisa Toto et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Toto, Lisa
Evangelista, Federica
Viggiano, Pasquale
Erroi, Emanuele
D'Onofrio, Giada
Libertini, Daniele
Porreca, Annamaria
D'Aloisio, Rossella
Mariacristina, Parravano
Di Antonio, Luca
Di Nicola, Marta
Mastropasqua, Rodolfo
Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
title Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
title_full Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
title_fullStr Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
title_full_unstemmed Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
title_short Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
title_sort changes in ocular blood flow after ranibizumab intravitreal injection for diabetic macular edema measured using laser speckle flowgraphy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035512/
https://www.ncbi.nlm.nih.gov/pubmed/32104710
http://dx.doi.org/10.1155/2020/9496242
work_keys_str_mv AT totolisa changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT evangelistafederica changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT viggianopasquale changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT erroiemanuele changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT donofriogiada changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT libertinidaniele changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT porrecaannamaria changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT daloisiorossella changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT mariacristinaparravano changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT diantonioluca changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT dinicolamarta changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy
AT mastropasquarodolfo changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy